Laser atherectomy was necessary due to significant calcification and fibrosis of the occlusion. The standard coronary laser catheter was used for 5 patients and the peripheral laser catheter was used for 6 patients. Laser was used to facilitate reverse CART in 5 patients and to debulk the antegrade reentry zone in 6 patients. Average laser fluence was 66 mJ/mm2 and laser time 75 AE 8 seconds. All target vessels were successfully recannulized and all patients were discharged from hospital uneventfully. One contained coronary perforation and one small aneurysm were observed in cases using reverse CART, neither of which were clinically significant. Thrombosis of the left main from the diagnostic catheter used to inject collaterals occurred in one patient. Intravascular ultrasound post-subintimal laser atherectomy showed an intact channel with surrounding medial and adventitial layers. Conclusions: We report the first successful use of subintimal laser atherectomy for percutaneous coronary interventions. The concern for coronary perforations and rupture has limited the use of laser to intraluminal debulking; however, we show that the hypertrophied medial layer in a chronically occluded vessel provided a safe zone for laser atherectomy, even at high energy levels.
Background: A promising variant of the STAR technique, called mini-STAR, has been recently described as successful antegrade rescue technique after failure revascularization by conventional techniques for coronary chronic total occlusion (CTO). This study sought to assess the long-term clinical and angiographic outcome of mini-STAR as a bail-out strategy for CTO revascularization. Methods: From March 2009 to September 2011, 100 patients (mean age 61.4 AE 10.9 years) underwent a successful revascularization for CTO lesion by mini-STAR technique as a bail-out strategy. Results: . Drug eluting stents (DES) were implanted in all cases with an angiographic success of 92%. At 2-year follow up, the MACE-free survival was 89.2 % with a target-vessel revascularization rate of 6.5%. Angiographic follow-up was performed in 72% of patients. CTO target-lesion restenosis was observed in 25% of patients, whereas reocclusion rate was 12.5%. At multivariate Cox analysis, final TIMI flow < 3 was related to MACE occurrence (HR: 5.9, 95% CI: 1.4 to 24.4; p¼0.013). Final TIMI flow < 3 (OR:5.41, 95% CI: 1.05 to 27.73; p ¼ 0.043) and CTO stent length (OR: 0.96, 95% CI: 0.93 to 0.99; p ¼ 0.017) were independent predictors of reocclusion. The independent variables related to restenosis were first-generation DES (OR: 4.10, 95% CI: 1.23 to 13.64; p ¼ 0.022) and CTO stent length (OR: 0.97, 95% CI: 0.95 to 1.00; p ¼ 0.027). Conclusions: As a bail out strategy for CTO lesions revascularization, the mini-STAR technique shows low MACE and target-lesion revascularization rates at long-term follow-up.
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Percutaneous intervention of circumflex chronic total occlusions is associated with worse procedural outcomes: insights from a multicenter US registry Results: The CTO target vessel was the RCA in 387 cases (61%), LAD in 132 (21%) and LCX in 117 (18%). LCX lesions were more tortuous and RCA lesions had higher occlusion length and J-CTO score, but were less likely to have a side branch at the proximal cap and had more developed collateral circulation. Procedural success was lower in LCX CTOs (84.6%), followed by RCA (91.7%) and LAD (94.7%) CTOs (p¼0.016). Major complications tended to occur more frequently in LCX PCI (4.3% vs. 1.0% for RCA vs. 2.3% for LAD, p¼0.07). LCX and RCA CTO PCI required higher fluoroscopy times [45 (30-74) Background: One of the reasons for the low application rates of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) by most physicians, may be uncertainty concerning the success rate of the procedure. Improved guidelines for case selection, may favourably impact these patients. Methods: During 2012-2014, 106 eligible patients who were scheduled for percutaneous recanalization of a true CTO were included prospectively in the study. 101 SATURDAY, SEPTEMBER 13, 2014, 5:00 PM-7:00 PM www.jacctctabstracts2014.com B62patients underwent multislice computed tomography (MSCT) prior to the procedure. By protocol we pre-defined the same 10 anatomic characteristics by conventional angiography (CA) and MSCT based on previously published independent predictors of failure and our team experience. Two-experienced interventional cardiologist and two imaging specialists, respectively, analysed CTO characteristics. Prospectively, the Japanese-CTO score of complexity was calculated by CA and MSCT. Results: According to the CA-Japanese-CTO score of complexity 47% of lesions were classified as difficult or very difficult. By CA 52% were severe calcified lesions. In most cases (88%) the strategy was antegrade. The total stent length implanted per lesion was of 51.6 AE 20.3mm. In all case last generation DES was implanted. Successful guidewire crossing was 86.4% and the overall success rate was 85.2%. Significant calcification by CA (37.5% vs. 11.5%, p ¼ 0.001) and by MSCT (> 50% cross sectional area) (26.6% vs. 60.0%, p ¼ 0.016) was more prevalent in failed cases. It is important to note a new anatomic characteristic "bad landing zone" (defined as distal vessel just after the CTO exit point, with reference diameter 2mm) by CA (30.5% vs. 63.3%, p ¼ 0.01) was more prevalent in failed cases. By multivariable logistic regression, the only independent predictor of procedural failure was the CA-J-CTO score (odds ratio (OR) 2.5, 95% confidence interval (CI) 1.37-4.59, p¼0.003, for each unit increase in J-CTO score) and silent ischemia as baseline clinic status before PCI-CTO (OR 4.71, CI 1.23-17.95, p¼0.02). Conclusions: According with the results of this prospective study, the Japanese-CTO score of complexity assessed by conventional angiograhy had a significant impact in procedural outcomes.
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Procedural outcomes of CTO specific intravascular ultrasound Navifocus WR-guided PCI for CTO Satoshi Kameda Background: At percutaneous coronary intervention (PCI) for chronic total occlusion (CTO), the first guidewire is sometimes inserted into the subintimal space, and in this situation the strategy of intravascular ultrasound (IVUS)-guided wiring, that is, leading the second guidewire into the true lumen under observing by IVUS from subintimal space, was the last procedure because of the absence of the suitable IVUS for this usage. Therefore we have produced CTO specific IVUS, which is named Navifocus WR, with Terumo Corp (Tokyo, Japan). It has a small profile transducer (2.5F) with short length of tip to transducer (9mm) and will be inserted into subintimal space with minimum vessel damage. It has been approved since September in 2012 in Japan. Methods: From September in 2012 to March in 2014, in 16 CTO cases, Navifocus WR was used during the antegrade PCI approach after the first guidewire was inserted into the subintimal space. We succeeded the Navifocus WR-guided antegrade wiring in 10 (63%) of 16 cases. The patients were divided into 2 groups based on the success or failure of Navifocus WR-guided antegrade wiring. Results: The reference diameter was larger in the success group compared to the failure group (2.87AE0.73 mm vs. 2.43AE0.39 mm, P¼0.2). The procedural time of IVUS-guided wiring was significantly shorter in the success group compared to the failure group (20.2AE27.2 minutes vs. 58.5AE41.2 minutes, P¼0.041). In the failure group, we changed to the retrograde approach, etc. and succeeded the PCI procedure in 15 (94%) of 16 cases. Conclusions: At CTO PCI, the success rate of Navifocus WR-guided wiring was acceptable and with the combination of the retrograde approach, etc the high success rate could be achieved.
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